Increased risk of breast cancer in neurofibromatosis type 1: current insights

References

• EvansDGHowardEGiblinCBirth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register serviceAm J Med Genet A2010152A232733220082463
   PubMed Web of Science ®Google Scholar
• UusitaloELeppävirtaJKoffertAIncidence and mortality of neurofibromatosis: a total population study in FinlandJ Invest Dermatol2015135390490625354145
   PubMed Web of Science ®Google Scholar
• EastonDFPonderMAHusonSMPonderBAAn analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genesAm J Hum Genet19935323053138328449
   PubMed Web of Science ®Google Scholar
• AbramowiczAGosMNeurofibromin in neurofibromatosis type 1 – mutations in NF1 gene as a cause of diseaseDev Period Med201418329730625182393
   PubMedGoogle Scholar
• EvansDGBowersNBurkitt-WrightENorthern UK NF1 Research NetworkComprehensive RNA analysis of the NF1 gene in classically affected NF1 meeting NIH criteria has high sensitivity and mutation negative testing is reassuring in isolated cases with pigmentary features onlyEBioMedicine2016721222027322474
   PubMed Web of Science ®Google Scholar
• MadanikiaSABergnerAYeXBlakeleyJOIncreased risk of BC in women with NF1Am J Med Genet A2012158A123056306023165953
   PubMed Web of Science ®Google Scholar
• UusitaloERantanenMKallionpääRADistinctive cancer associations in patients with neurofibromatosis type 1J Clin Oncol201634171978198626926675
   PubMed Web of Science ®Google Scholar
• JohannessenCMReczekEEJamesMFBremsHLegiusECichowskiKThe NF1 tumor suppressor critically regulates TSC2 and mTORProc Natl Acad Sci U S A2005102248573857815937108
   PubMed Web of Science ®Google Scholar
• HegedusBDasguptaBShinJENeurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanismsCell Stem Cell20071444345718371380
   PubMed Web of Science ®Google Scholar
• TongJHannanFZhuYBernardsAZhongYNeurofibromin regulates G protein-stimulated adenylyl cyclase activityNat Neurosci200252959611788835
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas NetworkComprehensive molecular portraits of human breast tumoursNature20124907418617023000897
   PubMed Web of Science ®Google Scholar
• Suárez-CabreraCQuintanaRMBravoAA transposon-based analysis reveals RASA1 is involved in triple-negative breast cancerCancer Res20177761357136828108518
   PubMed Web of Science ®Google Scholar
• WallaceMDPfefferleADShenLComparative oncogenomics implicates the neurofibromin 1 gene (NF1) as a breast cancer driverGenetics2012192238539622851646
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (NICE) NICE.org Available from: https://www.nice.org.uk/guidance/cg164/chapter/recommendations#summary-of-recommendations-on-surveillance-for-women-with-no-personal-history-of-breast-cancerAccessed March 5, 2017
   Google Scholar
• National Comprehensive Cancer Network (NCCN) website Available from: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#genetics_screeningAccessed March 5, 2017
   Google Scholar
• SørensenSAMulvihillJJNielsenALong-term follow-up of von Recklinghausen neurofibromatosis: survival and malignant neoplasmsN Engl J Med198631416101010153083258
   PubMed Web of Science ®Google Scholar
• ZöllerMRembeckBAkessonHOAngervallLLife expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Goteborg, SwedenActa Derm Venereol19957521361407604643
   PubMed Web of Science ®Google Scholar
• RasmussenSAYangQFriedmanJMMortality in neurofibromatosis 1: an analysis using U.S. death certificatesAm J Hum Genet20016851110111811283797
   PubMed Web of Science ®Google Scholar
• WalkerLTompsonDEastonDA prospective study of neurofibromatosis type 1 cancer incidence in the UKBr J Cancer200695223323816786042
   PubMed Web of Science ®Google Scholar
• SharifSMoranAHusonSMWomen with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screeningJ Med Genet200744848148417369502
   PubMed Web of Science ®Google Scholar
• WangXLevinAMSmolinskiSEVigneauFDLevinNKTainskyMABreast cancer and other neoplasms in women with neurofibromatosis type 1: a retrospective review of cases in the Detroit metropolitan areaAm J Med Genet A2012158A123061306422965642
   PubMed Web of Science ®Google Scholar
• SeminogOOGoldacreMJRisk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage studyBr J Cancer2013108119319823257896
   PubMed Web of Science ®Google Scholar
• UusitaloEKallionpääRAKurkiSBreast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factorsBr J Cancer2017116221121727931045
   PubMed Web of Science ®Google Scholar
• GokalpGHakyemezBKizilkayaEHaholuAMyxoid neurofibromas of the breast: mammographical, sonographical and MRI appearancesBr J Radiol200780958e234e23717959912
   PubMedGoogle Scholar
• ZhouYPanBMaoFA hidden breast lump covered by nipple appendices in a patient with von Recklinghausen disease: a case report and review of the literatureClin Breast Cancer2012121717522018828
   PubMed Web of Science ®Google Scholar
• LeachMOBoggisCRDixonAKMARIBS study groupScreening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)Lancet200536594731769177815910949
   PubMed Web of Science ®Google Scholar
• SharifSFernerRBirchJMSecond primary tumours in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapyJ Clin Oncol200624162570257516735710
   PubMed Web of Science ®Google Scholar
• SorlieTTibshiraniRParkerJRepeated observation of breast tumor subtypes in independent gene expression data setsProc Natl Acad Sci U S A2003100148418842312829800
   PubMed Web of Science ®Google Scholar
• DalyMBPilarskiRBerryMNCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017J Natl Compr Canc Netw201715192028040716
   PubMed Web of Science ®Google Scholar